Expert Opinion on Drug Safety

Killer fentanyl: is the fear justified?
pp. 213-217(5)
Authors: Fodale, Vincenzo; Mafrica, Federica; Santamaria, Letterio B; Coleman, John J

The safety of mycophenolate mofetil in pregnancy
pp. 219-222(4)
Authors: Pisoni, Cecilia N; D'Cruz, David P

Antidepressants use in pediatric populations
pp. 223-225(3)
Authors: Gören, Jessica L

Internet healthcare: do self-diagnosis sites do more harm than good?
pp. 227-229(3)
Authors: Ryan, Angela; Wilson, Sue

Understanding drug-induced torsades de pointes: a genetic stance
pp. 231-239(9)
Author: Kannankeril, Prince J

Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health
pp. 241-258(18)
Authors: Journé, Fabrice; Body, Jean-Jacques; Leclercq, Guy; Laurent, Guy

Raloxifene in breast cancer prevention
pp. 259-270(12)
Authors: Gennari, Luigi; Merlotti, Daniela; Paola, Vincenzo De; Nuti, Ranuccio

Helicobacter pylori eradication therapy: indications, efficacy and safety
pp. 271-281(11)
Authors: Kwok, Avelyn; Lam, Thao; Katelaris, Peter; Leong, Rupert WL

Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings
pp. 283-293(11)
Authors: Makinson, Alain; Moing, Vincent Le; Kouanfack, Charles; Laurent, Christian; Delaporte, Eric

Hypersensitivity reactions to cephalosporins
pp. 295-304(10)
Authors: Moreno, Esther; Macías, Eva; Dávila, Ignacio; Laffond, Elena; Ruiz, Arturo; Lorente, Félix

Challenges of characterizing proarrhythmic risk due to QTc prolongation induced by nonadjuvant anticancer agents
pp. 305-318(14)
Authors: Sarapa, Nenad; Britto, Margaret R

Safety issues in the management of autoimmune hepatitis
pp. 319-333(15)
Author: Czaja, Albert J